ClickCease
+1-915-850-0900 [email protected]
Select Page
El Paso Orthobiologics for Innovative Pain Management

El Paso Orthobiologics for Innovative Pain Management

El Paso Orthobiologics for Joint Pain and Healing

Abstract

As a Doctor of Chiropractic, Advanced Practice Registered Nurse, and certified functional medicine practitioner, I am constantly exploring the leading edge of musculoskeletal health. In this educational post, I will share key insights from the forefront of orthobiologics, a revolutionary field that harnesses your body’s own substances to heal injuries and manage chronic conditions such as osteoarthritis (OA). We will delve into the nuances of Platelet-Rich Plasma (PRP), discussing the critical importance of understanding its cellular composition—specifically, the roles of platelets versus pro-inflammatory neutrophils. We will also explore advanced techniques, such as micro-fragmented adipose tissue (MFAT) and subchondral bone injections, and examine the latest research and clinical applications. Throughout this discussion, I will explain how our multidisciplinary practice integrates these advanced biological treatments with our foundational principles of integrative chiropractic care, physical rehabilitation, and functional medicine. Our goal is to provide a comprehensive, patient-centered approach that not only addresses symptoms but also corrects the underlying biomechanical and physiological imbalances that contribute to joint degeneration, all under the expert medical direction of Dr. Maria Guadalupe Cardenas, MD.

El Paso Orthobiologics for Innovative Pain Management

Our Collaborative Care Model: The Synergy of Chiropractic and Medicine

At Injury Medical Clinic, our strength lies in our multidisciplinary team approach. I, Dr. Alex Jimenez (DC, APRN, FNP-BC, CFMP), work in close collaboration with our Medical Director, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a board-certified Internist with over 40 years of invaluable experience (NPI #1164426749, Texas MD License #J2933). This integrative model, common in advanced injury and wellness clinics, allows us to blend the best of different disciplines for superior patient outcomes.

  • Dr. Jimenez’s Role: I focus on the biomechanical, functional, and structural aspects of health. Through chiropractic adjustments, I address spinal and joint misalignments that create abnormal stress on the body. My expertise in functional medicine allows me to investigate and correct underlying metabolic and inflammatory issues. My role as a Family Nurse Practitioner enables me to bridge the gap between conservative care and medical interventions.
  • Dr. Cardenas’s Role: As the Medical Director, Dr. Cardenas provides essential medical oversight, ensuring all treatments are safe, appropriate, and aligned with the highest standards of medical care. Her deep knowledge of internal medicine is crucial for managing complex patient cases, especially those with comorbidities that could impact treatment outcomes. She collaborates on patient diagnoses, reviews treatment plans, and provides the necessary medical supervision for procedures that fall under the practice of medicine.

This partnership ensures that when we discuss and implement advanced therapies such as orthobiologics, we do so within a framework of comprehensive care. We can offer a spectrum of services from chiropractic adjustments and physical therapy to medically supervised regenerative procedures, all under one roof. This allows us to create truly personalized treatment plans that address the patient as a whole person, not just a symptom or a single joint.


The PRP Puzzle: Why Not All Platelet-Rich Plasma Is Created Equal

One of the most exciting and debated topics in orthobiologics is Platelet-Rich Plasma (PRP). The fundamental idea is simple: we concentrate the platelets from your blood and inject them into an injured area to stimulate healing. However, the details are crucial, and the clinical outcomes can vary dramatically based on the specific composition of the PRP.

It’s fascinating to look at the differences in preparation methods. For instance, European studies often describe manual preparation methods, which can yield a very different product from that of automated centrifuge systems commonly used in the United States. A key point of confusion in the literature and among practitioners concerns the white blood cell content of PRP, specifically the presence of neutrophils.

Leukocyte-Rich vs. Leukocyte-Poor PRP: The Neutrophil Question

When PRP was first being described, “leukocyte-rich” often implied it was rich in neutrophils. These are powerful immune cells that are excellent at fighting infection but are also highly pro-inflammatory. When injected into the sensitive, contained environment of a joint like the knee, a high concentration of neutrophils can trigger a significant inflammatory flare-up, leading to pain, swelling, and potentially even cartilage damage—an outcome we desperately want to avoid.

Many modern PRP systems in the U.S. are marketed as producing “leukocyte-poor” PRP. However, this term can be misleading. While these systems effectively reduce neutrophil counts, they often concentrate other white blood cell types, such as lymphocytes and monocytes. The total white blood cell count might remain the same or even increase, but the cell type has shifted.

My clinical takeaway for both patients and practitioners is this: Be meticulous.

  • Know Your System: If you are considering PRP, it’s crucial to understand what kind of preparation is being used. Ask the provider or the system manufacturer for data on the cellular composition. What is the typical platelet concentration? What are the final counts of neutrophils, lymphocytes, and monocytes?
  • The Differential is Key: The most important factor is the white blood cell differential. We generally want a preparation with a high concentration of platelets and monocytes (which can signal tissue repair) but a very low concentration of neutrophils. Injecting neutrophil-rich PRP into a joint with osteoarthritis is not a sound strategy and can lead to unhappy patients with increased pain and inflammation.

The future of this field may involve real-time analysis. I envision a time where we can aspirate fluid from a swollen knee, analyze its specific inflammatory profile in a lab, and then custom-tailor a biologic injection—be it a specific PRP formulation or another orthobiologic—to precisely counteract that patient’s unique inflammatory signature. Until then, diligence and a deep understanding of the product being used are paramount.

The Role of Integrative Chiropractic Care with PRP Therapy

When a patient receives PRP for a condition like knee osteoarthritis, the treatment doesn’t end with the injection. In our clinic, integrative chiropractic care is essential to maximizing the success of the biologic intervention.

  • Biomechanical Optimization: A degenerating knee is often the victim of poor biomechanics. There may be a pelvic tilt, a functional leg length discrepancy, or spinal misalignments that cause uneven weight distribution, placing excessive stress on one side of the joint. Through chiropractic adjustments, we can help restore proper alignment of the pelvis and spine, ensuring that forces are distributed more evenly through the lower extremities. This off-loading of the treated joint is critical; it creates a more favorable mechanical environment for the new tissue to regenerate and reduces the repetitive strain that caused the problem in the first place.
  • Neuromuscular Re-education: Our physical rehabilitation team works to strengthen weak muscles (such as the quadriceps and glutes) and release tight ones (such as the hamstrings). This corrects muscular imbalances that contribute to poor joint tracking and stability. Proper muscle function is vital for protecting the joint as it heals.
  • Reducing Systemic Inflammation: My functional medicine training enables me to address sources of systemic inflammation that can hinder healing. We may use dietary modifications, targeted nutritional supplements, and lifestyle coaching to lower the body’s overall inflammatory load, giving the PRP a better physiological environment in which to work its magic.

By combining the targeted regenerative power of PRP with a comprehensive plan to correct the underlying biomechanical and physiological dysfunctions, we give our patients the best possible chance for long-term success.

Micro-Fragmented Adipose Tissue (MFAT): A Powerful Second-Line Therapy

What happens when a patient has tried everything—physical therapy, bracing, cortisone shots, even PRP—and still suffers from persistent joint pain and swelling? For these individuals, who are often trying to delay or avoid a total knee replacement, we may consider a more advanced orthobiologic: micro-fragmented adipose tissue (MFAT), also known as a fat graft.

This procedure involves harvesting a small amount of fat, typically from the flank or abdomen, through a minimally invasive liposuction process. The fat is then specifically processed to create a micro-fragmented injectate rich in reparative cells, including mesenchymal stem cells (MSCs), which are contained within the fat tissue’s supportive structural matrix. This matrix, called the stromal vascular fraction (SVF), provides a natural scaffold and signaling environment for the cells.

Who Is a Candidate for MFAT?

We typically reserve MFAT as a second-line therapy for specific cases:

  1. Patients with Osteoarthritis and Persistent Effusions (Swelling): These are individuals whose knees remain swollen and painful despite other treatments.
  2. Post-Surgical Patients: Some patients elect to have an MFAT injection following an orthopedic surgery to provide a biologic boost to the healing process.
  3. Patients Seeking to Avoid Joint Replacement: These are often individuals who have exhausted other non-surgical options and are seeking a more powerful intervention to preserve their native joint.

I have been pleasantly surprised by the number of patients who have responded favorably to MFAT after failing to respond to other biologics. This suggests that the cellular and structural components of adipose tissue confer a unique and potent capacity for healing. Does it work for everyone? No, just like any other medical procedure. But for the right patient, it can be a game-changing option.

The harvesting procedure itself is very well-tolerated. Interestingly, data from the plastic surgery field show that liposuction performed on an awake patient (using local anesthetic) is significantly safer than when performed under general anesthesia. We perform this procedure in a specialized treatment room in our clinic. We use a tumescent solution—a mixture of saline and local anesthetic—which is infused into the harvest area. A critical pearl of this process is time. We let the solution sit for 20-30 minutes. This not only numbs the area completely but also makes the fat tissue easier to harvest. It’s a comfortable and safe in-office procedure.

Decompressing the Bone: The Subchondral Injection Approach

For many years, the focus of osteoarthritis treatment has been on the cartilage. But we now understand that OA is a disease of the whole joint, including the subchondral bone—the layer of bone just beneath the cartilage. In advanced OA, this bone can become stressed, leading to bone marrow lesions (which appear as bruises on MRI), increased intraosseous pressure, and sclerotic changes. This “sick bone” is a major source of pain and contributes to the progression of cartilage breakdown.

This understanding has led to the development of subchondral bone injections. The procedure involves using fluoroscopic (X-ray) guidance to precisely place a needle into the area of diseased subchondral bone and decompress it. This act of creating a channel into the bone may itself be therapeutic by relieving the high pressure that causes pain.

What Do We Inject?

Once decompression is achieved, a biologic agent can be injected. Studies have explored using various substances, including:

  • Bone Marrow Aspirate Concentrate (BMAC): Rich in stem cells and growth factors to stimulate bone healing.
  • Calcium Phosphate Cement: A synthetic bone graft substitute that provides structural support.

A significant body of literature, including a notable French paper, has shown impressive results, with some studies reporting that up to 80-95% of patients avoided joint replacement for many years after the procedure. However, a consistent finding across most subchondral injection studies is a failure rate of about 20%. This tells us that while it is a powerful intervention for about 80% of patients, it’s not a silver bullet.

Maximizing Success: It’s All About the Environment

The key to improving that 80% success rate lies in what we do after the needle comes out. We must change the environment that made the bone sick in the first place.

This is where the principles of integrative and functional care are non-negotiable.

  • Offloading the Joint: From an orthopedic perspective, this might mean a surgical osteotomy to realign the bone. From a non-surgical and chiropractic perspective, it means using an offloading brace, correcting biomechanics through chiropractic adjustments, and, most importantly, weight loss. Every pound of body weight lost reduces the force on the knee by four pounds.
  • Treating the Biomechanics: As my surgical colleagues often point out, you can’t ignore the “roof collapsing on the foundation.” If a patient has poor core stability, weak quadriceps, and valgus collapse (knock-knees) during movement, they are constantly putting compressive stress on that joint. No biologic injection can fix that. This is why our physical rehabilitation programs are so vital. We must rebuild the functional foundation to protect the biological repair.

Patients who fail these advanced procedures are often those whose underlying biomechanical and metabolic issues are not addressed. The more variables we can modify—from spinal alignment and muscle function to body weight and systemic inflammation—the greater the patient’s chance of long-term success. It’s a testament to the fact that true healing is never about a single magic injection; it’s about a comprehensive, integrated strategy.


References

Hernigou, P., Auregan, J. C., Dubory, A., Flouzat-Lachaniette, C. H., Chevallier, N., & Rouard, H. (2018). Subchondral bone or intra-articular injection of bone marrow concentrate: what is the best treatment for knee osteoarthritis? International Orthopaedics, 42(10), 2265–2272. https://doi.org/10.1007/s00264-018-3926-5

Laudy, S., Boughedda, R., Musquer, N., & Verdot, F. (2020). Efficacy of autologous platelet-rich plasma to treat knee osteoarthritis: a systematic review. International Orthopaedics, 44(9), 1711–1725. https://doi.org/10.1007/s00264-020-04664-8

Pak, J., Lee, J. H., & Lee, S. H. (2013). A novel biological therapy for knee osteoarthritis: A combination of intra-articular and intraosseous injections of autologous adipose tissue-derived stromal cells. Journal of Medical and Biological Engineering, 33(5), 554-561. https://doi.org/10.5405/jmbe.1394

Sánchez, M., Delgado, D., Anitua, E., & Orive, G. (2019). The inflammatory paradox of platelet-rich plasma. Seminars in Thrombosis and Hemostasis, 45(6), 577-588. https://doi.org/10.1055/s-0039-1693444

Chiropractic and Regenerative Joint Pain Care Strategies

Chiropractic and Regenerative Joint Pain Care Strategies

Chiropractic and Regenerative Joint Pain Care: An Evidence-Based Approach

Abstract

Welcome to our educational series. I’m Dr. Alexander Jimenez, and today, we’ll explore the sophisticated world of regenerative medicine, specifically focusing on platelet-rich plasma (PRP) and its applications in managing joint pain, particularly osteoarthritis. This post translates complex clinical research into practical insights, exploring patient selection, treatment protocols, and the crucial role of integrative care. We will discuss the science behind PRP, including platelet concentration, the debate between leukocyte-rich versus leukocyte-poor preparations, and how these factors influence patient outcomes. Furthermore, we’ll examine how we integrate these advanced biologic treatments with our foundational chiropractic and physical therapy principles to create a comprehensive, patient-centered journey toward healing and restored function. We’ll navigate the nuances of post-injection care, the timing of treatments relative to other interventions, such as cortisone shots, and the latest evidence-based strategies to optimize results. Our goal is to empower you with a clear understanding of how these modern therapies work synergistically with established musculoskeletal care, not just to alleviate pain but to foster true, long-term healing.

Chiropractic and Regenerative Joint Pain Care Strategies


Hello, I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. It’s a privilege to share insights from the forefront of musculoskeletal and regenerative medicine. In my practice, we are dedicated to merging the latest scientific advancements with a holistic, patient-first philosophy. Today, I want to guide you through a fascinating and rapidly evolving area: the use of platelet-rich plasma (PRP) for joint conditions like osteoarthritis. We will explore how we, as integrative practitioners, make clinical decisions based on cutting-edge research and how these decisions fit within a broader chiropractic and physical therapy framework to optimize your recovery.

Optimizing Patient Selection for Regenerative Therapies: Who is the Ideal Candidate?

A common and critical question I encounter is, “Am I a suitable candidate for PRP?” Patients often wonder if there are strict cutoffs based on age, body mass index (BMI), or the severity of their arthritis.

Based on the latest evidence and my clinical experience, the answer is more nuanced than simple metrics. While there can be a subtle bias against higher BMI, the primary predictor of a successful response to PRP is the nature of the patient’s symptoms, not their demographic profile.

  • Ideal Candidates: Patients who describe their pain as a broad, achy, and inflammatory sensation tend to respond remarkably well. This type of pain often signals an underlying inflammatory process that PRP is uniquely equipped to modulate. In these cases, age and the degree of arthritis seen on an X-ray are less critical factors. We have seen patients in their nineties achieve significant relief.
  • Less Predictable Candidates: Conversely, individuals who experience sharp, stabbing, or mechanical pressure-type pain often have a more complex clinical picture. This type of pain can indicate issues beyond simple inflammation, such as bone marrow lesions, significant meniscal tears, or other “pain generators” that create mechanical blocks or instability. While these patients may still benefit from PRP, our treatment algorithm must be expanded to address concurrent issues, often through targeted physical therapy and chiropractic adjustments.

It is a matter of managing expectations. For a patient with severe arthritis who is exploring alternatives to knee replacement, we might discuss the potential for a 30-60% improvement over several months. I am always transparent: no treatment is 100% effective. Our approach is to create a personalized, evidence-informed plan that maximizes your chances of success.

The Science of PRP: Leukocyte-Rich vs. Leukocyte-Poor

The conversation around PRP often involves technical terms like leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP). Leukocytes are white blood cells, and their presence in the PRP injectate is a subject of significant debate.

A preparation is generally considered “leukocyte-rich” if the concentration of white blood cells exceeds that in the patient’s baseline whole blood. Most commercial PRP systems produce a leukocyte-rich product. The key distinction lies in the types of leukocytes present. The current focus in research is on reducing pro-inflammatory neutrophils while preserving monocytes, which are crucial for tissue remodeling and healing.

  • Leukocyte-Poor (LP-PRP): This is often preferred for injections near sensitive structures, such as nerves or the spine, where minimizing the initial inflammatory response is paramount.
  • Leukocyte-Rich (LR-PRP): For most joint and soft tissue applications, a degree of inflammation is not only acceptable but beneficial. This initial inflammatory flare, driven by the leukocytes and platelets, is what kickstarts the healing cascade. Patients receiving LR-PRP might experience more swelling and soreness for a day or two, but this is a sign that the body’s regenerative engine is firing up.

At our clinic, we recognize that the most critical factor in treating conditions like osteoarthritis is the total platelet dose delivered to the joint. Research overwhelmingly supports that a higher platelet count correlates with better clinical outcomes. While we can fine-tune the leukocyte profile, we never want to sacrifice the platelet dose to do so.

The Cornerstone of Recovery: Integrating Chiropractic and Physical Therapy

Regenerative injections like PRP are powerful tools, but they are not a “magic bullet.” True and lasting healing requires a comprehensive approach that addresses the root cause of the joint dysfunction. This is where integrative chiropractic care and physical therapy become indispensable.

The human body is an intricate system of levers and pulleys. If a joint is in pain, it’s often due to improper biomechanics, muscular imbalances, or postural deficits that place abnormal stress on the joint. Injecting PRP can reduce inflammation and stimulate tissue repair, but if the underlying mechanical problems aren’t corrected, the joint will remain under duress, and the pain will likely return.

This is why our protocol is built on a foundation of musculoskeletal care:

  1. Chiropractic Adjustments: We use precise adjustments to restore proper joint alignment and mobility. For a knee, this involves assessing and correcting mechanics not just in the knee itself but also in the hips, ankles, and spine. A misaligned pelvis or a collapsed arch in the foot can profoundly alter the forces acting through the knee joint. By correcting these issues, we ensure that the healing environment stimulated by PRP is not compromised by ongoing mechanical stress.
  2. Targeted Physical Therapy: Our physical therapy programs are designed to complement both chiropractic adjustments and regenerative injections. The goals are to:
    • Strengthen Supporting Musculature: We build strength in the muscles around the affected joint (e.g., quadriceps, hamstrings, and glutes for the knee) to provide dynamic stability.
    • Improve Flexibility and Range of Motion: Gentle stretching and mobility exercises help prevent stiffness and ensure the joint can move through its full, healthy range of motion.
    • Neuromuscular Re-education: We retrain the body to move correctly, correcting faulty movement patterns that contributed to the initial injury. This is crucial for long-term prevention.

This synergistic approach ensures that we are not just treating the symptom (pain) but are fundamentally rebuilding the joint’s functional capacity. The PRP provides the biological “scaffolding” and signaling for repair, while chiropractic and physical therapy provide the mechanical and functional framework for that repair to be successful and durable.

Clinical Protocols and Timing: Maximizing Therapeutic Benefit

The timing and technique of regenerative treatments are critical. Many patients come to us having had previous cortisone injections. Corticosteroids are potent anti-inflammatories, but they are also catabolic, meaning they can break down tissue and suppress the very cellular activity that PRP aims to stimulate.

Therefore, we adhere to a strict washout period. Based on studies of steroid residency in joint spaces, we typically wait a minimum of 30 to 35 days after an intra-articular cortisone injection before administering PRP. This allows the steroid’s suppressive effects to dissipate, ensuring the joint environment is receptive to regenerative signals from platelets.

Dose and Volume: Customizing the Injection

A guiding principle in regenerative medicine is the delivery of an adequate platelet dose. The larger the joint and the more severe the condition, the more platelets are needed. This has led to innovative techniques for maximizing the therapeutic payload.

For a large joint like the knee, we might first draw off the most concentrated fraction after preparing the PRP. For example, if we process a blood draw and obtain 4-5 cc of PRP, the final 1-2 cc at the bottom of the syringe (closest to the red blood cell layer) will have the highest platelet concentration. In a patient with severe arthritis who can tolerate more volume, I might:

  1. Inject the most potent, platelet-dense fraction first.
  2. Follow this with the next-most concentrated layer.
  3. Finally, inject the remaining platelet-poor plasma (PPP), which contains valuable proteins and growth factors that help modulate inflammation.

This layering technique allows us to deliver a very high total number of platelets and other beneficial biological factors, essentially “hyper-dosing” the joint to maximize the healing response. For a large knee, we might inject up to 15 cc of total volume if the patient can comfortably accommodate it.

The research is detailed: dose matters. My clinical observations confirm that achieving a higher platelet count, especially in moderate-to-severe osteoarthritis, yields a more robust and lasting clinical improvement (Everhart et al., 2019).

The Role of Peptides and Other Biologics

The field of regenerative medicine is constantly exploring synergistic therapies. One area of growing interest is the combination of PRP with peptides like BPC-157. BPC-157 is a peptide chain known for its ability to promote angiogenesis (the formation of new blood vessels), which is fundamental to tissue healing.

While human data is still emerging, animal studies suggest that combining PRP with BPC-157 could enhance the healing response. The logic is compelling: PRP initiates the inflammatory and repair cascade, while BPC-157 may accelerate the development of a rich blood supply needed to fuel that repair process. This is an exciting frontier, and as more robust data becomes available, we will continue to integrate evidence-based combination therapies into our protocols.

As we continue this journey together, remember that our mission is to provide you with the most advanced, evidence-based, and personalized care possible. By integrating the biological power of regenerative medicine with the foundational principles of chiropractic and physical therapy, we can move beyond merely managing symptoms and guide you toward true, functional recovery.


References

  • Everhart, J. S., Cavendish, P. A., & Flanigan, D. C. (2019). Platelet-Rich Plasma Preparation and Composition. In D. C. Flanigan (Ed.), Platelet-Rich Plasma in Orthopaedics and Sports Medicine (pp. 11-20). Springer. https://link.springer.com/chapter/10.1007/978-3-030-01919-3_2
  • LaPrade, R. F., Dragoo, J. L., Rodeo, S. A., & Chu, C. R. (2021). The Orthobiologic Classification System: A Data-Driven Approach for the Standardization of Orthobiologic Reporting. The American Journal of Sports Medicine, 49(12), 3121–3129. https://doi.org/10.1177/03635465211029519
  • Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: A systematic review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495-505. https://doi.org/10.1016/j.arthro.2015.08.005
Mastodon